Rekombinantti IL-5-antagonisteja, jotka ovat käyttökelpoisia hoidettaessa IL-5:een liittyviä sairauksia

PCT No. PCT/US95/17082 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/21000 PCT Pub. Date Jul. 11, 1996Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: THEISEN,TIMOTHY WAYNE, AMES,ROBERT S, MCMILLAN,LYNETTE JANE, GROSS,MITCHELL STUART, APPELBAUM,EDWARD ROBERT, CHAIKEN,IRWIN M, COOK,RICHARD M, HOLMES,STEPHEN DUDLEY
Format: Patent
Sprache:fin ; swe
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PCT No. PCT/US95/17082 Sec. 371 Date Jun. 19, 1997 Sec. 102(e) Date Jun. 19, 1997 PCT Filed Dec. 22, 1995 PCT Pub. No. WO96/21000 PCT Pub. Date Jul. 11, 1996Chimeric, humanized and other IL-5 mAbs, derived from high affinity neutralizing mAbs, pharmaceutical compositions containing same, methods of treatment and diagnostics are provided.